Data / Form D filings / TENGION INC
TENGION INC: Form D filings
TENGION INC, a biotechnology company in Winston-Salem, NC, filed 4 Form D notices with the SEC between 2011 and 2013. The latest, on August 7, 2013, reports $74.3 million sold of a $74.3 million offering to 22 investors.
Find out what TENGION INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3929 WESTPOINT BLVD., SUITE G, Winston-Salem, NC, 27103
- Phone
- (336) 722-5855
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1296391
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2013 | New notice | $74,304,002 | $74,304,002 | $0 | 22 | Jun 28, 2013 | sec.gov |
| Oct 10, 2012 | New notice | $15,005,251 | $15,005,251 | $0 | 15 | Oct 2, 2012 | sec.gov |
| Sep 21, 2012 | New notice | $1,000,000 | $1,000,000 | $0 | 9 | Sep 7, 2012 | sec.gov |
| Mar 16, 2011 | New notice | $31,354,278 | $31,354,278 | $0 | 43 | Mar 1, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| DIANE L. JORKASKY | Director | |
| LORIN J. RANDALL | Director | |
| CARL-JOHAN L. DALSGAARD | Director | |
| TIM L. BERTRAM | Executive Officer | |
| JOHN L. MICLOT | Executive Officer, Director | |
| A. BRIAN DAVIS | Executive Officer | |
| RICHARD E. KUNTZ | Director | |
| DAVID J. SCHEER | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Aug 5, 2013 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TENGION INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.